Basilea Pharmaceutica
BSLN.SW
#6651
Rank
C$1.12 B
Marketcap
C$90.58
Share price
0.57%
Change (1 day)
-4.62%
Change (1 year)

Earnings for Basilea Pharmaceutica (BSLN.SW)

Earnings in 2025: C$81.65 Million

According to Basilea Pharmaceutica's latest financial reports the company's current earnings are C$0.29 Billion. In 2025 the company made an earning of C$81.65 Million a decrease over its 2024 earnings that were of C$94.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Basilea Pharmaceutica from 2002 to 2025

Annual earnings

Year Earnings Change
2025C$81.65 M-13.15%
2024C$94.01 M436.2%
2023C$17.53 M-5.02%
2022C$18.46 M-276.18%
2021-C$10.48 Million-55.31%
2020-C$23.45 Million-28%
2019-C$32.57 Million-27.06%
2018-C$44.65 Million62.13%
2017-C$27.54 Million-60.94%
2016-C$70.49 Million-19.67%
2015-C$87.75 Million48.25%
2014-C$59.19 Million12.95%
2013-C$52.41 Million-35.16%
2012-C$80.83 Million-5.75%
2011-C$85.76 Million-152.57%
2010C$0.16 B-199.59%
2009-C$0.17 Billion-15.54%
2008-C$0.2 Billion22.84%
2007-C$0.16 Billion60.07%
2006-C$98.63 Million85.69%
2005-C$53.12 Million-43.04%
2004-C$93.26 Million47.04%
2003-C$63.42 Million-37.99%
2002-C$0.11 Billion